Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Mendel

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoN Bischofberger, M J Hitchcock, M S Chen, et al.
Anti-Cancer Drug Design|July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agentD B Mendel, A D Laird, B D Smolich, et al.
Journal of the American Chemical Society|January 29, 1997
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activityC U Kim, W Lew, M A Williams, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
High levels of HER-2 expression alter the ability of epidermal growth factor receptor (EGFR) family tyrosine kinase inhibitors to inhibit EGFR phosphorylation in vivoJ G Christensen, R E Schreck, E Chan, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoN Bischofberger, M J Hitchcock, M S Chen, et al.
Anti-Cancer Drug Design|July 11, 2000
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agentD B Mendel, A D Laird, B D Smolich, et al.
Journal of the American Chemical Society|January 29, 1997
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activityC U Kim, W Lew, M A Williams, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Identification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071W Li, P A Escarpe, E J Eisenberg, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infectionD B Mendel, C Y Tai, P A Escarpe, et al.
Pageof 5